Inventor · disambiguated record
Peter Robert Baum
Also filed as: BAUM PETER · BAUM PETER R · BAUM PETER ROBERT
31 granted patents·40 pending applications·823 citations·filing 1993–2021
97Inventor score
Files withIMMUNEX CORP29SILVERBACK THERAPEUTICS INC16EMERGENT PRODUCT DEV SEATTLE7TRUBION PHARMACEUTICALS INC4BAUM PETER R2
Top patents by PatentIndex Score
71 records- 0198US5728813AAntibodies directed against elk ligandIMMUNEX CORP·Filed 1996·Granted Mar 17, 1998·165 cites·4 claims
- 0297US5457035ACytokine which is a ligand for OX40IMMUNEX CORP·Filed 1993·Granted Oct 10, 1995·331 cites·8 claims
- 0396US7939640B2Antibodies that bind B7L-1IMMUNEX CORP·Filed 2010·Granted May 10, 2011·19 cites·2 claims
- 0495US7741115B2Antibodies that bind LDCAMIMMUNEX CORP·Filed 2008·Granted Jun 22, 2010·22 cites·5 claims
- 0595US7695937B2Polynucleotides encoding C-type lectin polypeptides and methods of use thereofIMMUNEX CORP·Filed 2008·Granted Apr 13, 2010·25 cites·7 claims
- 0694US11179473B2Nectin-4 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Nov 23, 2021·7 cites·30 claims
- 0794US10428045B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2019·7 cites·39 claims
- 0893US10519131B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·13 claims
- 0993US10442790B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Granted Oct 15, 2019·5 cites·41 claims
- 1093US6512095B2Molecules designated B7L-1IMMUNEX CORP·Filed 2001·Granted Jan 28, 2003·26 cites·27 claims
- 1190US10239862B2Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Granted Mar 26, 2019·7 cites·21 claims
- 1288US7846434B2Materials and methods for improved immunoglycoproteinsTRUBION PHARMACEUTICALS INC·Filed 2008·Granted Dec 7, 2010·14 cites·17 claims
- 1387US9493564B2CD86 antagonist multi-target binding proteinsTHOMPSON PETER ARMSTRONG·Filed 2009·Granted Nov 15, 2016·12 cites·33 claims
- 1487US5670625AElk ligand fusion proteinsIMMUNEX CORP·Filed 1995·Granted Sep 23, 1997·35 cites·12 claims
- 1585US8632774B2Antagonists of IL-6MISHER LYNDA·Filed 2009·Granted Jan 21, 2014·20 cites·12 claims
- 1685US5512457ACytokine designated elk ligandIMMUNEX CORP·Filed 1994·Granted Apr 30, 1996·48 cites·13 claims
- 1783US7659385B2Polynucleotides encoding molecules designated LDCAMIMMUNEX CORP·Filed 2008·Granted Feb 9, 2010·3 cites·14 claims
- 1881US5627267ACytokine designated elk ligandIMMUNEX CORP·Filed 1995·Granted May 6, 1997·23 cites·10 claims
- 1980US7402655B2Molecules designated LDCAMIMMUNEX CORP·Filed 2001·Granted Jul 22, 2008·8 cites·13 claims
- 2080US7175849B2Nectin polypeptidesIMMUNEX CORP·Filed 2001·Granted Feb 13, 2007·18 cites·32 claims
- 2174US8674078B2Methods of using BTL-II proteinsBAUM PETER R·Filed 2012·Granted Mar 18, 2014·2 cites·20 claims
- 2273US7244822B2BTL-II proteinsIMMUNEX CORP·Filed 2003·Granted Jul 17, 2007·4 cites·26 claims
- 2371US2008075724A1Molecules designated B7L-1IMMUNEX CORP·Filed 2007·Application pending·0 cites
- 2470US2020031798A1Benzazepine compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2569US8383106B2Materials and methods for improved immunoglycoproteinsEMERGENT PRODUCT DEV SEATTLE·Filed 2010·Granted Feb 26, 2013·2 cites·11 claims
- 2666US5783665ACytokine which is a ligand for OX40IMMUNEX CORP·Filed 1995·Granted Jul 21, 1998·14 cites·3 claims
- 2766US2009226417A1Human B7 polypeptidesIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 2865US12364768B2Nectin-4 antibody conjugates and uses thereofARARIS BIOTECH AG·Filed 2021·Granted Jul 22, 2025·0 cites·21 claims
- 2965US11541126B1Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·30 claims
- 3065US2004022767A1Novel cytokine designated elk ligandFiled 2003·Application pending·0 cites
- 3163US7709618B2BTL-II nucleic acidsIMMUNEX CORP·Filed 2007·Granted May 4, 2010·0 cites·40 claims
- 3263US2023062712A1Anti-asgr1 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3361US2003144478A1Molecules designated B7L-1IMMUNEX CORP·Filed 2002·Application pending·0 cites
- 3459US2011217302A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2009·Application pending·0 cites
- 3559US2013084603A1B7l-1 polynucleotidesIMMUNEX CORP·Filed 2012·Application pending·0 cites
- 3658US2009258005A1Therapeutic compositions and methodsTRUBION PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3757US2004204568A1Molecules designated LDCAMIMMUNEX CORP·Filed 2003·Application pending·0 cites
- 3856US2003134306A1Human and murine cytokine polypeptidesFiled 2002·Application pending·0 cites
- 3955US8048994B2C-type lectin polypeptide, polynucleotide and methods of making and use thereofIMMUNEX CORP·Filed 2010·Granted Nov 1, 2011·0 cites·2 claims
- 4055US7396662B2C-type lectin polypeptidesIMMUNEX CORP·Filed 2002·Granted Jul 8, 2008·0 cites·4 claims
- 4154US2005233418A1Cytokine polypeptidesIMMUNEX CORP·Filed 2004·Application pending·0 cites
- 4254US2010215572A1Methods of treatment using ldcamIMMUNEX CORP·Filed 2010·Application pending·0 cites
- 4354US2003180309A1Human B7 polypeptidesFiled 2002·Application pending·0 cites
- 4454US2010150948A1Materials and methods for improved immunoglycoproteinsTRUBION PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4553US2022362396A1Amino-pyrazinecarboxamide compounds, conjugates, and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4653US2006110772A1Human and murine cytokine polypeptidesIMMUNEX CORP·Filed 2005·Application pending·0 cites
- 4752US2010144640A1Molecules designated b7l-1IMMUNEX CORP·Filed 2010·Application pending·0 cites
- 4852US2007081973A1Cytokine polypeptidesIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 4950US2013189261A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
- 5050US2020113912A1Methods and Compositions for the Treatment of Disease with Immune Stimulatory ConjugatesSILVERBACK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Robert Baum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →